slotkoers
Korea S.E.
00:00:00 17-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6.480
KRW
|
-0,15%
|
|
+1,89%
|
-1,97%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
269.932
|
187.532
|
310.369
|
313.540
|
213.543
|
179.354
|
Bedrijfswaarde
1 |
187.050
|
120.470
|
250.784
|
267.826
|
195.284
|
162.653
|
K/w-verhouding
|
51,4
x
|
9,32
x
|
22,1
x
|
24,9
x
|
17,6
x
|
-8,66
x
|
Dividendrendement
|
2,63%
|
5,05%
|
4,46%
|
4,37%
|
5,08%
|
6,05%
|
Marktkapitalisatie/omzet
|
1,51
x
|
1,06
x
|
1,79
x
|
1,77
x
|
1,17
x
|
1,1
x
|
Bedrijfswaarde/omzet
|
1,04
x
|
0,68
x
|
1,44
x
|
1,51
x
|
1,07
x
|
1
x
|
Bedrijfswaarde/EBITDA
|
6,88
x
|
3,87
x
|
9,75
x
|
11,8
x
|
13
x
|
-8,51
x
|
Bedrijfswaarde/FCF
|
4,97
x
|
-61
x
|
-31
x
|
41,9
x
|
-70,4
x
|
319
x
|
FCF Yield
|
20,1%
|
-1,64%
|
-3,22%
|
2,39%
|
-1,42%
|
0,31%
|
Price to Book
|
1,27
x
|
0,83
x
|
1,18
x
|
1,2
x
|
0,83
x
|
0,79
x
|
Aantal aandelen (in duizenden)
|
23.678
|
23.678
|
27.712
|
27.383
|
27.134
|
27.134
|
Referentieprijs
2 |
11.400
|
7.920
|
11.200
|
11.450
|
7.870
|
6.610
|
Datum van publicatie
|
11-03-19
|
13-03-20
|
19-03-21
|
21-03-22
|
22-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
179.316
|
176.500
|
173.828
|
177.611
|
182.718
|
162.674
|
EBITDA
1 |
27.193
|
31.121
|
25.724
|
22.770
|
15.016
|
-19.106
|
Bedrijfsresultaat (EBIT)
1 |
20.385
|
24.155
|
18.950
|
15.758
|
8.312
|
-24.955
|
Operationele Marge
|
11,37%
|
13,69%
|
10,9%
|
8,87%
|
4,55%
|
-15,34%
|
Resultaat voor belastingen (EBT)
1 |
20.233
|
34.945
|
19.339
|
18.432
|
17.941
|
-18.503
|
Nettowinst (verlies)
1 |
5.242
|
20.126
|
12.459
|
12.672
|
12.161
|
-20.708
|
Nettomarge
|
2,92%
|
11,4%
|
7,17%
|
7,13%
|
6,66%
|
-12,73%
|
WPA
2 |
221,8
|
850,0
|
507,8
|
460,4
|
447,0
|
-763,2
|
Free Cash Flow
1 |
37.643
|
-1.973
|
-8.079
|
6.388
|
-2.773
|
510,2
|
FCF-marge
|
20,99%
|
-1,12%
|
-4,65%
|
3,6%
|
-1,52%
|
0,31%
|
Kasstroomconversie (ebitda)
|
138,43%
|
-
|
-
|
28,05%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
718,08%
|
-
|
-
|
50,41%
|
-
|
-
|
Dividend per aandeel
2 |
300,0
|
400,0
|
500,0
|
500,0
|
400,0
|
400,0
|
Datum van publicatie
|
11-03-19
|
13-03-20
|
19-03-21
|
21-03-22
|
22-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
82.882
|
67.062
|
59.585
|
45.714
|
18.259
|
16.701
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
37.643
|
-1.973
|
-8.079
|
6.388
|
-2.773
|
510
|
ROE (netto-inkomsten/eigen vermogen)
|
2,43%
|
10,1%
|
5,17%
|
4,83%
|
4,68%
|
-8,53%
|
ROA (netto-inkomsten/totale activa)
|
5%
|
5,54%
|
4,09%
|
3,38%
|
1,72%
|
-5,17%
|
Totale activa
1 |
104.760
|
363.522
|
304.536
|
375.288
|
705.159
|
400.603
|
Nettoactief per aandeel
2 |
8.941
|
9.574
|
9.461
|
9.540
|
9.479
|
8.409
|
Cashflow per aandeel
2 |
1.272
|
2.659
|
577,0
|
654,0
|
536,0
|
434,0
|
Capex
1 |
3.931
|
2.055
|
28.591
|
3.926
|
10.574
|
6.290
|
Capex/omzet
|
2,19%
|
1,16%
|
16,45%
|
2,21%
|
5,79%
|
3,87%
|
Datum van publicatie
|
11-03-19
|
13-03-20
|
19-03-21
|
21-03-22
|
22-03-23
|
21-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -1,97% | 131 mln. | | +21,59% | 44,15 mld. | | +23,03% | 23,02 mld. | | +18,22% | 15,33 mld. | | +12,26% | 13,74 mld. | | +52,55% | 12,16 mld. | | -10,02% | 6,84 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +12,92% | 5,66 mld. |
Generieke geneesmiddelen
|